Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-11-08 5:20 pm Purchase | 2021-10-28 | 13G | CULLINAN THERAPEUTICS INC CGEM | BIOTECHNOLOGY VALUE FUND L P | 2,606,806 6.000% | 2,606,806 (New Position) | Filing History |
| 2021-10-29 4:29 pm Purchase | 2021-10-21 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | BIOTECHNOLOGY VALUE FUND L P | 3,003,879 6.500% | 3,003,879 (New Position) | Filing History |
| 2021-09-15 5:17 pm Purchase | 2021-08-16 | 13G | MOLECULAR PARTNERS AG ADS MOLN | BIOTECHNOLOGY VALUE FUND L P | 2,498,901 7.700% | 2,498,901 (New Position) | Filing History |
| 2021-09-15 5:14 pm Purchase | 2021-09-13 | 13D | RAIN ONCOLOGY INC. RAIN | BIOTECHNOLOGY VALUE FUND L P | 2,945,807 15.700% | 400,554 (+15.74%) | Filing History |
| 2021-09-07 5:26 pm Purchase | 2021-08-26 | 13G | WHITEHAWK THERAPEUTICS, INC. C WHWK | BIOTECHNOLOGY VALUE FUND L P | 1,147,052 5.500% | 1,147,052 (New Position) | Filing History |